| Financial Year |
March 31 2022 |
| Monetary Funds |
1,516,963,181.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,800,000.00 |
| Accounts Receivable |
1,868,266,704.10 |
| Advances to Suppliers |
820,795,953.65 |
| Other Receivables |
111,136,219.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,561,804,849.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,014,265.46 |
| Other Current Assets |
205,702,960.10 |
| Total Current Assets |
12,578,235,873.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,138,662.99 |
| Investment Properties |
27,919,297.10 |
| Fixed Assetes |
4,725,499,615.43 |
| Under-construction Projects |
455,953,928.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
963,027,370.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
479,740,940.85 |
| Other Non-Current Assets |
64,078,547.58 |
| Sub-Total of Non-Current Assets |
6,749,358,362.38 |
| Total Assets |
19,327,594,236.11 |
| Short-Term Loans |
1,777,547,658.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,808,398,670.56 |
| Accounts Payable |
793,442,284.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
198,013,953.61 |
| Taxes Payable |
527,629,107.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
211,333,689.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
292,131,845.55 |
| Other Current Liabilities |
213,662,091.18 |
| Sub-Total of Current Liabilities |
8,056,351,277.35 |
| Long-term Loans |
1,731,925,737.78 |
| Bonds Payable |
1,357,700,029.79 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,337,594.13 |
| Other Non-Current Liabilities |
175,660,377.38 |
| Sub-Total of Non-Current Liabilities |
3,833,268,198.23 |
| Total Liabilities |
11,889,619,475.58 |
| Paid-In Capital(Or Share Stock) |
530,777,557.00 |
| Capital Surplus |
2,436,600,516.32 |
| Surplus Reserve |
181,247,883.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,999,433,629.99 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,437,974,760.53 |
| Owner's Equity（Stockholder's Equity） |
7,437,974,760.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,327,594,236.11 |
